Benzinga

Benzinga

Benzinga

samedi, août 29

Quoin Pharmaceuticals Ltd

QNRXNASDAQ
Trade with Public
Trade with Public
$6.12
0.9618.72%
À la clôture: Aug 28, 5:00 PM EST
$5.70
-0.42-6.86%
Après les heures: 7:59 PM EST
PRO
Pourquoi cela bouge-t-il ?:QNRX shares are trading higher after the company announced interim Phase 2/...
AperçuActualitésPrévisions de résultatsObjectifs de coursDonnées financièresSentimentActionnariatComparerRapport sur les stocks

Quoin Pharmaceuticals Financials

Quoin Pharmaceuticals (QNRX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Quoin Pharmaceuticals Q2 EPS $(1.90) Misses $(1.61) Estimate

Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.90) per share which missed the analyst consensus estimate of $(1.61) by 18.01 percent. This is a 69.75 percent increase over losses of $(6.28) per
Benzinga Newsdesk

PRO
Quoin Pharmaceuticals Q1 EPS $(1.77) Misses $(1.72) Estimate

Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.77) per share which missed the analyst consensus estimate of $(1.72) by 2.91 percent. This is a 72.77 percent increase over losses of $(6.50) per share
Benzinga Newsdesk

PRO
Quoin Pharmaceuticals Q4 EPS $(1.74) Beats $(4.02) Estimate

Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.74) per share which beat the analyst consensus estimate of $(4.02) by 56.72 percent. This is a 85.96 percent increase over losses of $(12.39) per share
Benzinga Newsdesk

Earnings Scheduled For March 26, 2026

Benzinga Insights

PRO
Quoin Pharmaceuticals Q3 EPS $(6.71) Misses $(6.50) Estimate

Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(6.71) per share which missed the analyst consensus estimate of $(6.50) by 3.15 percent. This is a 59.21 percent increase over losses of $(16.45) per
Benzinga Newsdesk

Earnings Scheduled For November 6, 2025

Benzinga Insights

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved